BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Stem Cells » HSCs » Page 27

Hematopoietic Stem Cells (HSCs)

CarePilot and “Cord for Life” Find Innovative Way to Make Cord Blood Banking Affordable

September 8, 2015 By Cade Hildreth (CEO) Leave a Comment

CarePilot and Lifeforce Cryobanks Announce Partnership to Make Cord Blood Banking Affordable

In August 2014, CarePilot USA, based in Newport Beach, California, announced a collaboration with the “Cord for Life” storage program offered by Lifeforce Cryobanks, a company based in Altamonte Springs, Florida.  Through this partnership, CarePilot is now offering significant discounts on the collection, processing, and storage of newborn umbilical cord blood.  Specifically, CarePilot is offering two, six, and 21-year storage plans at major discounts relative to the market rates offered by the “Cord for Life” program. [Read more…]

Filed Under: Cord Blood, HSCs, MSCs Tagged With: alliances, carepilot, cord blood banking, lifeforce cryobanks, market news, strategic partnership

Top 5 Stem Cell Influencers on Twitter

September 7, 2015 By Cade Hildreth (CEO) Leave a Comment

Top 5 Influencers on Twitter for Stem Cells

Do You Know the Top 5 Stem Cell Influencers on Twitter?

Twitter is one of the most widely used social media platforms that exists. There are now 316 million monthly active users and 500 million Tweets sent per day, according to Twitter’s company statistics.  In fact, every single minute of the day, there are nearly 350,000 Tweets posted to Twitter. Importantly, it is now one of the 9th most most visited website in the world, according to Alexa, an Amazon company that ranks relative traffic for websites. Within the United States, Twitter is the 8th most visited website, an absolutely incredible feat.  [Read more…]

Filed Under: Adipose SCs, HSCs, iPS Cells, MSCs, Neural Stem Cells, Stem Cells Tagged With: influencers, market news, stem cells, tweets, twitter

Epic Year for Regenerative Medicine Investments

July 17, 2015 By Cade Hildreth (CEO) Leave a Comment

EPIC YEAR FOR REGENERATIVE MEDICINE INVESTMENTS

In the past twelve months, regenerative medicine investments gained momentum, as new and promising clinical data got released. The momentum has been growing in recent years, enabling the cell therapy and genome editing sectors to evolve into a global industry.

[Read more…]

Filed Under: Adipose SCs, HSCs, iPS Cells, MSCs, Neural Stem Cells, Stem Cells Tagged With: financial events, Juno Therapeutics, mesenchymal stem cells, regenerative medicine, regenerative medicine industry

July is National Cord Blood Awareness Month

July 15, 2015 By Cade Hildreth (CEO) Leave a Comment

July National Cord Blood Month

July is National Cord Blood Awareness Month. It is a time during which the importance of cord blood and tissue stem cells is celebrated. Importantly, hematopoietic stem cells (HSCs) from cord blood can now be used to treat more than 80 diseases and conditions. Mesenchymal stem cells present in cord tissue are also being explored in a wide range of clinical trials.

Cord Blood Awareness

There are three primary categories of people who need to increase their awareness about the importance of cord blood stem cells. These categories include:

  1. Expectant (pregnant) parents
  2. Extended support networks for parents, including brothers, sisters, grandparents, aunts, uncles and friends
  3. Medical practitioners, including nurses and Ob/Gyns

[Read more…]

Filed Under: Cord Blood, HSCs, MSCs Tagged With: cord blood

3 Eerie Similarities between the Acquisition of Cord Blood Registry® (CBR) and ViaCord

July 9, 2015 By Cade Hildreth (CEO) Leave a Comment

CBR® ACQUIRED BY AMAG PHARMA FOR SAME MULTIPLE ON REVENUE AS PERKINELMER PAID FOR VIACORD

Cord Blood Registry® (CBR) recently made headlines by announcing that it had entered into a definitive agreement to be acquired by AMAG Pharmaceuticals for $700M. While the announcement was new, there were aspects of the deal that seemed eerily familiar.
[Read more…]

Filed Under: Cord Blood, HSCs Tagged With: AMAG Pharmaceuticals, cord blood, Cord Blood Registry, PerkinElmer, viacord

  • « Previous Page
  • 1
  • …
  • 25
  • 26
  • 27
  • 28
  • 29
  • …
  • 31
  • Next Page »

Nanocellect

Marathon Products

Kimera Society

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram

Cart

Top Rated Products

  • Job Posting on BioInformant <Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience $297
  • U.S. Cord Blood Banking Survey <Cord Blood Banking Survey of U.S. Parents [2017] $197
  • Exosome Companies 2020 <Global Database of Exosome Companies $149 $97

Featured Posts

Who discovered stem cells?

Who Discovered Stem Cells? The Answers Revealed

iPSC derived cell therapeutics

The Pipeline for iPSC-Derived Cell Therapeutics in 2022

Stem cell companies

List of Stem Cell Companies Worldwide (2022)

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.